Headlines about Utah Medical Products (NASDAQ:UTMD) have been trending somewhat positive on Monday, according to Accern. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Utah Medical Products earned a news impact score of 0.16 on Accern’s scale. Accern also gave news articles about the medical instruments supplier an impact score of 47.0606928935157 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Utah Medical Products (NASDAQ:UTMD) traded down $0.90 during trading hours on Monday, reaching $74.80. 3,700 shares of the company’s stock were exchanged, compared to its average volume of 13,241. The firm has a market cap of $278.30, a P/E ratio of 20.33 and a beta of 0.75. Utah Medical Products has a twelve month low of $58.50 and a twelve month high of $77.95.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 3rd. Shareholders of record on Friday, December 15th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date of this dividend is Thursday, December 14th. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.27. Utah Medical Products’s dividend payout ratio is currently 28.80%.

Separately, BidaskClub raised shares of Utah Medical Products from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/utah-medical-products-utmd-receives-media-sentiment-score-of-0-16/1701074.html.

Utah Medical Products Company Profile

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Insider Buying and Selling by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.